Advertisement

Digestive Diseases and Sciences

, Volume 62, Issue 2, pp 358–371 | Cite as

Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients

  • Tamara Vorobjova
  • Helerin Raikkerus
  • Lumme Kadaja
  • Ija Talja
  • Oivi Uibo
  • Kaire Heilman
  • Raivo Uibo
Original Article

Abstract

Background

Impaired intestinal integrity, including increased permeability of the small bowel mucosa, has been shown in patients with celiac disease (CD) as well as with type 1 diabetes (T1D). Zonulin (ZO, pre-haptoglobin), a tight junction regulator, plays a particular role in the regulation of intestinal barrier function and in the pathogenesis of the above-mentioned diseases.

Aim

To investigate whether enteroviruses (EVs) and immunoregulatory cells are associated with intestinal permeability in patients with CD alone and with coexistent T1D.

Materials and Methods

Altogether 80 patients (mean age 10.68 ± 6.69 years) who had undergone small bowel biopsy were studied. Forty patients with functional dyspepsia and normal small bowel mucosa formed the control group. The circulating ZO level in sera was evaluated using ELISA. The densities of EV, FOXP3+ regulatory T cells (Tregs), indoleamine 2,3-dioxygenase (IDO+) dendritic cells (DCs) and glutamic acid dexarboxylase (GAD)65+ cells in small bowel mucosa were investigated by immunohistochemistry. The expression analysis of FOXP3, tight junction protein 1 (TJP1), gap junction (GJA1), IDO and CD103 genes was evaluated by real-time PCR.

Results

The ZO level was higher in CD patients compared to subjects with a normal small bowel mucosa, particularly in those with Marsh IIIc atrophy (p = 0.01), and correlated with the density of EV (r = 0.63; p = 0.0003) and IDO+ DCs (r = 0.58; p = 0.01) in the small bowel mucosa. The density of GAD65+ epithelial cells was correlated with the density of EV (r = 0.59; p = 0.03) and IDO+ DCs (r = 0.78; p = 0.004) in CD patients. The relative expression of FOXP3 mRNA in the small bowel mucosa tissue was significantly higher in patients with CD, compared to subjects with a normal mucosa, and correlated with the density of EV (r = 0.62; p = 0.017) as well as with the relative expression of IDO mRNA (r = 0.54; p = 0.019).

Conclusions

The CD is associated with elevation of the circulating ZO level, the value of which correlates with the density of EV in CD patients with severe atrophic changes in the small bowel mucosa, particularly in cases of concomitant T1D. The CD is also characterized by the close relationship of the density of GAD65+ epithelial cells with the EV, ZO level and IDO+ DCs.

Keywords

Zonulin Enteroviruses Indoleamine 2,3-dioxygenase (IDO+) dendritic cells GAD65 Small bowel mucosa Immunohistochemistry Celiac disease 

Notes

Acknowledgments

We would like to thank Dr. Tiina Rägo from the Children’s Clinic of Tartu University Hospital, Tartu, for providing a part of the clinical material and Dr. Kaja Metsküla for performing the GAD65 Autoantibody ELISA assay. Mrs. Anu Kaldmaa from the Department of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, and Mrs. Merje Jakobson from the Department of Pathology, Tartu University Hospital are acknowledged for their assistance with the laboratory procedures.

Funding

This study was supported by Grants from the Estonian Research Foundation (No. 8334), by the EU Regional Developmental Fund and by Grants from the Estonian Ministry of Education and Research (SF 0180035s08 and IUT20-43).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Sapone A, de Magistris L, Pietzak M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55:1443–1449.CrossRefPubMedGoogle Scholar
  2. 2.
    Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes. The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;10:2555–2562.CrossRefGoogle Scholar
  3. 3.
    Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci. 2009;1165:195–205.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability and its expression in celiac disease. Lancet. 2000;355:1518–1519.CrossRefPubMedGoogle Scholar
  5. 5.
    Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91:151–175.CrossRefPubMedGoogle Scholar
  6. 6.
    Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol. 2008;24:701–706.CrossRefPubMedGoogle Scholar
  7. 7.
    Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol. 2011;33:45–55.CrossRefPubMedGoogle Scholar
  8. 8.
    Sarmiento L, Galvan JA, Cabrera-Rode E, et al. Type 1 diabetes associated and tissue transglutaminase autoantibodies in patients without type 1 diabetes and celiac disease with confirmed viral infections. J Med Virol. 2012;84:1049–1053.CrossRefPubMedGoogle Scholar
  9. 9.
    Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochim Biophys Acta. 2009;1788:832–841.CrossRefPubMedGoogle Scholar
  10. 10.
    Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in celiac disease: insight into mechanisms and relevance to pathogenesis. Gut. 2012;61:1355–1364.CrossRefPubMedGoogle Scholar
  11. 11.
    Vorobjova T, Uibo O, Ojakivi I, et al. Lower expression of tight junction protein 1 gene and increased FOXP3 expression in the small bowel mucosa in celiac disease and associated type 1 diabetes mellitus. Int Arch Allergy Immunol. 2011;156:451–461.CrossRefPubMedGoogle Scholar
  12. 12.
    Vorobjova T, Uibo O, Heilman K, Uibo R. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients. World J Gastroenterol. 2015;21:439–452.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113:4435–4440.PubMedGoogle Scholar
  14. 14.
    Drago S, El Asmar R, Di Pierro M, et al. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol. 2006;41:408–419.CrossRefPubMedGoogle Scholar
  15. 15.
    Lammers KM, Lu R, Brownley J, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008;135:e3.Google Scholar
  16. 16.
    Mazzini E, Massimiliano L, Penna G, Rescigno M. Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1+ macrophages to CD103+ dendritic cells. Immunity. 2014;40:248–261.CrossRefPubMedGoogle Scholar
  17. 17.
    Neijssen J, Pang B, Neefjes J. Gap junction-mediated intercellular communication in the immune system. Prog Biophys Mol Biol. 2007;94:207–218.CrossRefPubMedGoogle Scholar
  18. 18.
    Sáez PJ, Shoji KF, Aguirre A, Sáez JC. Regulation of hemichannels and gap junction channels by cytokines in antigen-presenting cells. Mediat Inflamm. 2014;2014:742734.CrossRefGoogle Scholar
  19. 19.
    Matsue H, Yao J, Matsue K, et al. Gap junction-mediated intercellular communication between dendritic cells (DCs) is required for effective activation of DCs. J Immunol. 2006;176:181–190.CrossRefPubMedGoogle Scholar
  20. 20.
    Mendoza-Naranjo A, Bouma G, Pereda C, et al. Functional gap junctions accumulate at the immunological synapse and contribute to T cell activation. J Immunol. 2011;187:3121–3132.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Bracken S, Byrne G, Kelly J, Jackson J, Feighery C. Altered gene expression in highly purified enterocytes from patients with active coeliac disease. BMC Genomics. 2008;9:377.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Karlsen AE, Hagopian WA, Grubin CE, et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA. 1991;88:8337–8341.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Uibo R, Lernmark Ǻ. GAD65 autoimmunity-clinical studies. Adv Immunol. 2008;100:39–78.CrossRefPubMedGoogle Scholar
  24. 24.
    Vaarala O. Gut and the induction of immune tolerance in type 1 diabetes. Diab Metab Res Rev. 1999;15:353–361.CrossRefGoogle Scholar
  25. 25.
    Auricchio R, Paparo F, Maglio M, et al. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes. 2004;53:1680–1683.CrossRefPubMedGoogle Scholar
  26. 26.
    Uibo R, Panarina M, Teesalu K, et al. Coeliac disease in patients with type 1 diabetes: A condition with distinct changes in intestinal immunity? Cell Mol Immunol. 2011;8:150–156.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Paronen J, Klemetti P, Kantele JM, et al. Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor α4β7-integrin. Diabetes. 1997;46:583–588.CrossRefPubMedGoogle Scholar
  28. 28.
    Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 1994;94:2125–2129.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Jones DB, Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia. 1996;39:1318–1324.CrossRefPubMedGoogle Scholar
  30. 30.
    Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes. 2000;49:1319–1324.CrossRefPubMedGoogle Scholar
  31. 31.
    Frisk G, Tuvemo T. Enterovirus infections with β-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies. J Med Virol. 2004;73:450–459.CrossRefPubMedGoogle Scholar
  32. 32.
    Wang FY, Watanabe M, Zhu RM, Maemura K. Characteristic expression of gamma-aminobutyric acid and glutamate decarboxylase in rat jejunum and its relation to differentiation of epithelial cells. World J Gastroenterol. 2004;10:3608–3611.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Walker-Smith J, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of celiac disease. Report of working group of European Society of Pediatric Gastroenterology and Nutrition. Arch Dis Child. 1990;65:909–911.CrossRefGoogle Scholar
  34. 34.
    Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology. 1992;102:330–354.CrossRefPubMedGoogle Scholar
  35. 35.
    Viskari H, Ludvigsson J, Uibo R, et al. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol. 2004;72:610–617.CrossRefPubMedGoogle Scholar
  36. 36.
    Hovi T, Roivainen M. Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus. J Clin Microbiol. 1993;31:1083–1087.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)). Methods. 2001;25:402–408.CrossRefPubMedGoogle Scholar
  38. 38.
    Jayashree B, Bibin YS, Prabhu D, et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem. 2014;388:203–210.CrossRefPubMedGoogle Scholar
  39. 39.
    Zhang D, Zhang L, Zheng Y, Yue F, Russell RD, Zeng Y. Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res Clin Pract. 2014;106:312–318.CrossRefPubMedGoogle Scholar
  40. 40.
    Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci. 2010;55:1026–1031.CrossRefPubMedGoogle Scholar
  41. 41.
    Rallabhandi P. Gluten and celiac disease—an immunological perspective. J AOAC Int. 2012;95:349–355.CrossRefPubMedGoogle Scholar
  42. 42.
    Oikarinen M, Tauriainen S, Honkanen T, et al. Detection of enteroviruses in the intestine of type 1 diabetes patients. Clin Exp Immunol. 2008;151:71–75. Epub 2007 Nov 7.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Oikarinen M, Tauriainen S, Oikarinen S, et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes. 2012;61:687–691.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia. 2009;52:1143–1151.CrossRefPubMedGoogle Scholar
  45. 45.
    Dotta F, Censini S, van Halteren AG, et al. Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA. 2007;104:5115–5120.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Sadeharju K, Lönnrot M, Kimpimäki T, et al. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children. Diabetologia. 2001;44:818–823.CrossRefPubMedGoogle Scholar
  47. 47.
    Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Diabetologia. 2001;44:818–823.CrossRefGoogle Scholar
  48. 48.
    Hyland NP, Cryan JF. A gut feeling about GABA: focus on GABA(B) receptors. Front Pharmacol. 2010;1:124.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Krecsmarik M, Katarova Z, Bagyánszki M, Szabó G, Fekete E. Gastrointestinal phenotype of GAD67lacZ transgenic mice with early postnatal lethality. Histol Histopathol. 2005;20:75–82.PubMedGoogle Scholar
  50. 50.
    Bhat R, Axtell R, Mitra A, et al. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA. 2010;107:2580–2585.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Munn DH, Sharma MD, Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 2002;297:1867–1870.CrossRefPubMedGoogle Scholar
  52. 52.
    Cherayil BJ. Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation. Inflamm Bowel Dis. 2009;15:1391–1396.CrossRefPubMedGoogle Scholar
  53. 53.
    Matteoli G, Mazzini E, Iliev ID, et al. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut. 2010;59:595–604.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Immunology, Institute of Biomedicine and Translational MedicineUniversity of TartuTartuEstonia
  2. 2.Department of Pathophysiology, Institute of Biomedicine and Translational MedicineUniversity of TartuTartuEstonia
  3. 3.Department of Pediatrics, Institute of Clinical MedicineUniversity of TartuTartuEstonia
  4. 4.Children’s ClinicTartu University HospitalTartuEstonia
  5. 5.Tallinn Children’s HospitalTallinnEstonia

Personalised recommendations